Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
50 Years to 85 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Between the ages of 50 and 85 years old
Have contact with a responsible caregiver 3 or more days per week
Be male or a female who is surgically sterilized or one year post menopausal
Current diagnosis of severe or unstable cardiovascular or other diseases
Current diagnosis of active, uncontrolled seizure disorder, Parkinson's disease or Alzheimer's disease